Re: Osteoporosis after orchiectomy for prostate cancer [5]

Journal of Urology

Volumn 158, Issue 4, 1997, Pages 1529-1530

  Daniell, H W ^a   Krongrad, A ^a   Levis, S ^a   Ross, B A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN;

AGING; ANDROGEN SYNTHESIS; BONE ATROPHY; BONE METABOLISM; DEPRESSION; FRACTURE; HORMONE DEFICIENCY; HUMAN; LETTER; MALE; ORCHIECTOMY; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY;

EID: 0030757754     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(01)64271-x     Document Type: Letter

References (21)

1. Vanderschueren D. Van Herck E. Schot P. Rush E. Einhorn T. Geusens P. Bouillon R. The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biomechanical testing. Calc. Tissue Int. 53 1993 342
2. Vanderschueren D. Van Herck E. Suiker A.M. Visser W.J. Schot L.P. Chung K. Lucas R.S. Einhorn T.A. Bouillon R. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J. Bone Min. Res. 8 1993 801
3. Finkelstein J.S. Neer R.M. Biller B.M. Crawford J.D. Klibanski A. Osteopenia in men with a history of delayed puberty. New Engl. J. Med. 326 1992 600
4. Simonin R. Nicolino-Peltier C. Gainlet P. Analogues de la gonadoreline associes aux anti-androgenes dans le traitement des metastases osseuses du cancer de la prostate. Leur utilisation peut-elle induire une osteoporose? Presse Med. 18 1989 2023
5. Horan A.H. Re: Osteoporosis as a complication of orchiectomy in 2 elderly men with prostatic cancer J. Urol. 155 1996 1395
6. McGrath S.A. Diamond T. Osteoporosis as a complication of orchiectomy in 2 elderly men with prostatic cancer J. Urol. 154 1995 535
7. Clarke N.W. McClure J. George N.J. The effects of orchiectomy on skeletal metabolism in metastatic prostate cancer Scand. J. Urol. Nephrol. 27 1993 475
8. Collinson M.P. Tyrrel C.J. Hutton C. Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate. Calc. Tissue Int. 54 1994 327
9. Tanaka H. Furukawa Y. Fukunaga K. Fukunaga M. Bone mineral density for patients with bone metastasis of prostate cancer: a preliminary report. Adv. Exp. Med. Biol. 324 1992 217
10. Goldray D. Weisman Y. Jaccard N. Merdler C. Chen J. Matzkin H. Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). J. Clin. Endocr. Metab. 76 1993 288
11. Meier D.E. Orwoll E.S. Keenan E.J. Fagerstrom R.M. Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. J. Amer. Ger. Soc. 35 1987 189
12. Jonler M. Madsen F.A. Rhodes P.R. Sall M. Messing E.M. Bruskewitz R.C. A prospective study of quantification of urinary incontinence and quality of life in patients undergoing radical retropubic prostatectomy. Urology 48 1996 433
13. Lu-Yao G.L. Potosky A.L. Albertsen P.C. Wasson J.H. Barry M.J. Wennberg J.E. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J. Nat. Cancer Inst. 88 1996 166
14. Burris A.S. Banks S.M. Carter C.S. Davidson J.M. Sherins R.J. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J. Androl. 13 1992 297
15. Wang C. Alexander G. Berman N. Salehian B. Davidson T. McDonald V. Steiner B. Hull L. Callegari C. Swerdloff R.S. Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. J. Clin. Endocr. Metab. 81 1996 3578
16. Herr H.W. Kornblith A.B. Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 71 1993 1143
17. Riis B.J. Christiansen C. Johansen J.S. Jacobson J. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J. Clin. Endocr. Metab. 70 1990 920
18. Horsman A. Jones M. Francis R. Nordin C. The effects of estrogen dose on postmenopausal bone loss. New Engl. J. Med. 309 1983 1405
19. Eriksson S. Eriksson A. Stege R. Carlstrom K. Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens. Calc. Tissue Int. 57 1995 97
20. Levis, S., Kim, C., Roos, B. A. and Krongrad, A.: Do estrogens protect against bone loss in men treated for prostate cancer? Proceedings of 76th annual meeting of the Endocrine Society, p. 1565, 1994.
21. Lukkarinen O. Kontturi M. Comparison of a long-acting LHRH agonist and polyoestradiol phosphate in the treatment of advanced prostatic carcinoma. An open prospective, randomized multicentre study. Scand. J. Urol. Nephrol. 28 1994 171